China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode
China challenged America's dominance in manufacturing, technology and artificial intelligence. Now, it is threatening another American stronghold: the pharmaceutical industry.
Chinese biotech companies are developing breakthrough drugs faster and cheaper than their American counterparts. One Chinese cancer drug, ivonescimab, is emerging as a potential challenger to Keytruda, Merck's $31-billion blockbuster. Meanwhile, Western pharmaceutical giants are striking multibillion-dollar licensing deals with Chinese innovators.
But Washington is worried. Could America's growing dependence on Chinese…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.